«Wegovy (semaglutide): a new weight loss drug for chronic weight management». Journal of Investigative Medicine, vol. 70, 1, January 2022, pàg. 5–13. DOI: 10.1136/jim-2021-001952. PMC: 8717485. PMID: 34706925.
«Clinical review of subcutaneous semaglutide for obesity». Journal of Clinical Pharmacy and Therapeutics, vol. 47, 2, February 2022, pàg. 184–193. DOI: 10.1111/jcpt.13574. PMID: 34964141.
«Efficacy and safety of semaglutide for weight management: evidence from the STEP program». Postgraduate Medicine, vol. 134, sup1, January 2022, pàg. 5–17. DOI: 10.1080/00325481.2022.2147326. PMID: 36691309.
«Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes». Canadian Journal of Diabetes, vol. 43, 2, March 2019, pàg. 136–145. DOI: 10.1016/j.jcjd.2018.05.008. PMID: 30195966.
«Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel». Journal of Clinical Pharmacology, vol. 55, 5, May 2015, pàg. 497–504. DOI: 10.1002/jcph.443. PMC: 4418331. PMID: 25475122.
«Wegovy (semaglutide): a new weight loss drug for chronic weight management». Journal of Investigative Medicine, vol. 70, 1, January 2022, pàg. 5–13. DOI: 10.1136/jim-2021-001952. PMC: 8717485. PMID: 34706925.
«Clinical review of subcutaneous semaglutide for obesity». Journal of Clinical Pharmacy and Therapeutics, vol. 47, 2, February 2022, pàg. 184–193. DOI: 10.1111/jcpt.13574. PMID: 34964141.
«Efficacy and safety of semaglutide for weight management: evidence from the STEP program». Postgraduate Medicine, vol. 134, sup1, January 2022, pàg. 5–17. DOI: 10.1080/00325481.2022.2147326. PMID: 36691309.
«Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes». Canadian Journal of Diabetes, vol. 43, 2, March 2019, pàg. 136–145. DOI: 10.1016/j.jcjd.2018.05.008. PMID: 30195966.
«Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel». Journal of Clinical Pharmacology, vol. 55, 5, May 2015, pàg. 497–504. DOI: 10.1002/jcph.443. PMC: 4418331. PMID: 25475122.